Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Tyson Ventures has returned for the plant-based shellfish substitute provider's series A round, bumping its total funding up to $26m.

On-demand ride provider Grab's financial services offshoot has secured the funding in a round led by Hanwha's Asset Management unit.

Discovery has provided about a third of the $81.7m closed by GB News as it prepares to launch its right-wing current affairs channel later this year.

The oncolytic virus therapy-based cancer drug developer is based on research at Salk Institute and has raised $77m in its series A round.

The oncolytic virus therapy-based cancer drug developer raised $77m in a GV-backed series A round as it prepares to file an IND application next year.

Ionis Pharmaceuticals and Johnson & Johnson Innovation – JJDC were among the investors in a round that will fund development of Aro's centyrin-RNA conjugate medicines.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Today’s deal net round ups the smaller investments from across the university innovation ecosystem that have occurred over the holiday period.

The Archermind-backed operating system developer was reportedly valued at $734m valuation in a $168m round led by Beijing E-Town.